Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDunelm Regulatory News (DNLM)

Share Price Information for Dunelm (DNLM)

Share Price is delayed by 15 minutes
Get Live Data
760.50    -3.50 (-0.46%)
Bid:
760.00
Ask:
761.00
Spread: 1.00 (0.132%)
Market Cap: £1.53b
DNLM Live PriceLast checked at - London Stock Exchange

Intraday Dunelm Share Chart

Director/PDMR Shareholding

20 Dec 2006 16:00

Dunelm Group plc20 December 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIALRESPONSIBILITY OR CONNECTED PERSONS This form is intended for use by an issuer to make a RIS notification requiredby DR 3.1.4R(1). (1) An issuer making a notification in respect of a transaction relating to the shares or debentures of the issuer should complete boxes 1 to 16, 23 and 24. (2) An issuer making a notification in respect of a derivative relating to the shares of the issuer should complete boxes 1 to 4, 6, 8, 13, 14, 16, 23 and 24. (3) An issuer making a notification in respect of options granted to a director/person discharging managerial responsibilities should complete boxes 1 to 3 and 17 to 24. (4) An issuer making a notification in respect of a financial instrument relating to the shares of the issuer (other than a debenture) should complete boxes 1 to 4, 6, 8, 9, 11, 13, 14, 16, 23 and 24. Please complete all relevant boxes in block capital letters. 1. Name of the issuer Dunelm Group plc 2. State whether the notification relates to (i) a transaction notified inaccordance with DR 3.1.4R(1)(a); or (ii) DR 3.1.4(R)(1)(b) a disclosure made in accordance with section 324 (asextended by section 328) of the Companies Act 1985; or (iii) both (i) and (ii) (iii), both (i) and (ii) 3. Name of person discharging managerial responsibilities/director David Stead 4. State whether notification relates to a person connected with a persondischarging managerial responsibilities/director named in 3 and identify theconnected person Director named in 3 5. Indicate whether the notification is in respect of a holding of the personreferred to in 3 or 4 above or in respect of a non-beneficial interest Director named in 3 6. Description of shares (including class), debentures or derivatives orfinancial instruments relating to shares Ordinary Shares of 1p each 7. Name of registered shareholders(s) and, if more than one, the number ofshares held by each of them Named in 3 8 State the nature of the transaction Exercise of approved options and subsequent sale 9. Number of shares, debentures or financial instruments relating to sharesacquired 400,000 10. Percentage of issued class acquired (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.2% 11. Number of shares, debentures or financial instruments relating to sharesdisposed 187,543 12. Percentage of issued class disposed (treasury shares of that class shouldnot be taken into account when calculating percentage) 0.0937% 13. Price per share or value of transaction Exercise Price: 43.35p per share Sale Price: 223p per share 14. Date and place of transaction 19 December 2006 15. Total holding following notification and total percentage holding followingnotification (any treasury shares should not be taken into account whencalculating percentage) 212,457 (0.1063%) 16. Date issuer informed of transaction 19 December 2006 If a person discharging managerial responsibilities has been granted options bythe issuer complete the following boxes 17 Date of grant N/A 18. Period during which or date on which it can be exercised N/A 19. Total amount paid (if any) for grant of the option N/A 20. Description of shares or debentures involved (class and number) 1p Ordinary 21. Exercise price (if fixed at time of grant) or indication that price is to befixed at the time of exercise N/A 22. Total number of shares or debentures over which options held followingnotification N/A 23. Any additional information The anticipated exercise of options and connected sale of shares by David Steadwas highlighted on page 30 of the Dunelm Group plc prospectus published at thetime of its initial public offering. The sale of shares has been carried out inorder to fund the cost of exercise of the options, and related taxation andother costs. 24. Name of contact and telephone number for queries David Stead 0116 2644 356 Name and signature of duly authorised officer of issuer responsible for makingnotification David Stead, Finance Director Date of notification 20 December 2006 END This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
9th Sep 20257:00 amRNSPreliminary Results
31st Jul 20257:00 amRNSTotal Voting Rights
17th Jul 20257:00 amRNSFourth quarter and full year trading update
14th Jul 202512:30 pmRNSDirector Declaration
7th Jul 202512:30 pmRNSAppointment of CEO
1st Jul 20257:00 amRNSTotal Voting Rights
17th Jun 20257:00 amRNSDirector/PDMR Shareholding
30th May 20257:00 amRNSTotal Voting Rights
8th May 20257:00 amRNSDirector/PDMR Shareholding
6th May 20257:00 amRNSAppointment of Katharine Poulter as NED
30th Apr 20257:00 amRNSTotal Voting Rights
17th Apr 20257:00 amRNSThird quarter trading update
14th Apr 20257:00 amRNSBlock Listing Six Monthly Return
1st Apr 20259:50 amRNSTotal Voting Rights
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20251:00 pmRNSPurchases of Shares During Open Periods
11th Feb 20257:00 amRNSCEO succession
11th Feb 20257:00 amRNSInterim Results
31st Jan 20257:00 amRNSTotal Voting Rights
16th Jan 20257:00 amRNSSecond quarter and first half trading update
31st Dec 20247:00 amRNSTotal Voting Rights
18th Dec 20247:00 amRNSDirector Declaration
29th Nov 202411:00 amRNSTotal Voting Rights
21st Nov 20243:18 pmRNSResults of AGM
20th Nov 20247:00 amRNS-RAcquisition of Home Focus
1st Nov 20241:00 pmRNSDirector/PDMR Shareholding
31st Oct 202411:00 amRNSTotal Voting Rights
30th Oct 20243:00 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSFirst quarter trading update
18th Oct 20244:00 pmRNSSale of Shares by Concert Party and AGM Notice
14th Oct 20247:00 amRNSDirector Declaration
10th Oct 202410:01 amRNSAnnual report and accounts and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.